4-nitro-N-(4-(5,6,7-trimethoxy-4-oxo-4H-chromen-2-yl)phenyl)benzamide

ID: ALA5280817

Max Phase: Preclinical

Molecular Formula: C25H20N2O8

Molecular Weight: 476.44

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc2oc(-c3ccc(NC(=O)c4ccc([N+](=O)[O-])cc4)cc3)cc(=O)c2c(OC)c1OC

Standard InChI:  InChI=1S/C25H20N2O8/c1-32-21-13-20-22(24(34-3)23(21)33-2)18(28)12-19(35-20)14-4-8-16(9-5-14)26-25(29)15-6-10-17(11-7-15)27(30)31/h4-13H,1-3H3,(H,26,29)

Standard InChI Key:  JAHHEMMLRUIDPY-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   -4.2842   -0.6169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5696   -0.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8578   -0.6164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8578   -1.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5678   -1.8535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2842   -1.4454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9989   -1.8579    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7135   -1.4454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1400   -1.8558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4283   -1.4391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4301   -0.6180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1451   -0.2056    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7155   -0.2055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7153    0.6197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0024    1.0303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7123    0.6176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7139   -0.2034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0021   -0.6199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4270    1.0302    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1417    0.6176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8562    1.0302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8565    1.8555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5694    2.2662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2842    1.8535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2858    1.0324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5740    0.6159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1417   -0.2074    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1400   -2.6810    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9989   -0.2043    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9989    0.6208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5678   -2.6786    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2825   -3.0912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9988    2.2660    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7135    1.8535    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9989    3.0912    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  2  0
  1  6  1  0
  6  7  1  0
  7  8  1  0
  4  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  3 12  1  0
 13 11  1  0
 14 13  2  0
 15 14  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 13 18  1  0
 16 19  1  0
 19 20  1  0
 20 21  1  0
 22 21  2  0
 23 22  1  0
 24 23  2  0
 25 24  1  0
 26 25  2  0
 21 26  1  0
 20 27  2  0
  9 28  2  0
  1 29  1  0
 29 30  1  0
  5 31  1  0
 31 32  1  0
 33 24  1  0
 33 34  1  0
 33 35  2  0
M  CHG  2  33   1  34  -1
M  END

Alternative Forms

  1. Parent:

    ALA5280817

    ---

Associated Targets(Human)

EKVX (44102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-92 (41141 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H226 (44470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H23 (49055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H522 (44358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UO-31 (46270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hs-578T (29457 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 476.44Molecular Weight (Monoisotopic): 476.1220AlogP: 4.65#Rotatable Bonds: 7
Polar Surface Area: 130.14Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 14.00CX Basic pKa: CX LogP: 3.53CX LogD: 3.53
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.30Np Likeness Score: -0.22

References

1. Hassan AHE, Lee KT, Lee YS..  (2020)  Flavone-based arylamides as potential anticancers: Design, synthesis and in vitro cell-based/cell-free evaluations.,  187  [PMID:31877541] [10.1016/j.ejmech.2019.111965]

Source